AKT1 and metastatic prostate carcinoma: Thus, our findings suggest that small molecule inhibitors, such as MK591 induces apoptosis in C4-2B prostate cancer cells which is independent of Akt inhibition, and that MK591 may prevent metastatic prostate cancer via down-regulation of PKC-epsilon and c-Myc oncogenic signaling.